Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

Stefanie Geyh, Simin Öz, R-P Cadeddu, +13

Leukemia

Regenerative MedicineChromatinMds ResultsInsufficient Stromal SupportExtracellular Matrix +8

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

Thomas Schroeder, Akos Czibere, Uwe Platzbecker, +13

Leukemia

Cell TherapyTransplantationMarrow TransplantationFirst Salvage TherapyStem Cell Transplantation +5

Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

Thomas Schroeder, Elena Rachlis, Gesine Bug, +20

Biology of Blood and Marrow Transplantation

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

Ulrich Steidl, Ralf Kronenwett, Ulrich‐Peter Rohr, +10

Blood

Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia

Stefanie Geyh, Manuel Rodríguez‐Paredes, Paul Jäger, +12

Leukemia

Hematological MalignancyFunctional InhibitionMedicineMixed-phenotype Acute LeukemiaHematology +8

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

Hartmut Goldschmidt, K. Elias, Uta Bertsch, +31

The Lancet Haematology

Transplantation-eligible PatientsHematological MalignancyPart 1TransplantationMedicine +7

Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma

Martin Kropff, Nicola Lang, Guido Bisping, +12

British Journal of Haematology

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

Guido Kobbe, Philipp Schneider, Ulrich‐Peter Rohr, +7

Bone Marrow Transplantation

InflammationTransplantationAutoimmune DiseaseImmunosuppressive TherapyImmunology +8

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

Ulrich Steidl, Simone Bork, Sebastian Schaub, +15

Blood

Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma

Patric Kröpil, Roland Fenk, Lars Benjamin Fritz, +4

European Radiology

Hematological MalignancyMedical ImagingHematologyMyeloid NeoplasiaMultiple Myeloma +8